Related Experiment Video
Updated: May 5, 2026

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
[Subretinal neovascular membrane in angioid streaks treated with intravitreal bevacizumab]
A García-López1, C González-Castaño1
1Servicio de Oftalmología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
Introduction:
Angioid streaks are breaks in Bruch's membrane that may be associated, among others, with pseudoxanthoma elasticum. Its most common complication is the development of subretinal neovascular membranes (SRNVM) and the decreased vision this entails.
Case Report:
A 28 year old woman with angioid streaks and SRNVM in the left eye, who received 3 injections of intravitreal bevacizumab, with rapid improvement in vision and stability during 11 months follow up. The finding of angioid streaks led to the diagnosis of pseudoxanthoma elasticum.
Conclusion:
Intravitreal bevacizumab should be considered as an effective treatment option for choroidal neovascularization associated with angioid streaks.
Insights
Intravitreal bevacizumab effectively treated subretinal neovascular membranes (SRNVM) in a patient with angioid streaks and pseudoxanthoma elasticum, improving vision. This treatment offers a promising option for associated choroidal neovascularization.
Area of Science:
- Ophthalmology
- Medical Genetics
Background:
- Angioid streaks are breaks in Bruch's membrane, often linked to genetic disorders like pseudoxanthoma elasticum.
- Subretinal neovascular membranes (SRNVM) are a common, vision-threatening complication of angioid streaks.
Observation:
- A case report details a 28-year-old woman diagnosed with pseudoxanthoma elasticum due to angioid streaks.
- The patient presented with SRNVM in her left eye, leading to decreased vision.
Findings:
- Three intravitreal bevacizumab injections were administered to the affected eye.
- Rapid visual improvement and sustained stability were observed over an 11-month follow-up period.
Implications:
- Intravitreal bevacizumab demonstrates efficacy in managing choroidal neovascularization secondary to angioid streaks.
- This treatment approach offers a potential therapeutic strategy for patients with pseudoxanthoma elasticum and related ocular complications.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy

